1. Sugiero revisar el siguiente posteo:
Partos y puerperios en tiempos del coronavirus.https://elcoronavirusdewuhan.blogspot.com/2020/03/partos-y-puerperios-en-tiempos-del.html
2. Compilación de textos:
Un análisis de 38 mujeres embarazadas con COVID-19, sus recién nacidos y la transmisión materno-fetal de SARS-CoV-2: infecciones por coronavirus maternos y resultados del embarazo.
An Analysis of 38 Pregnant Women with
COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of
SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes.
Arch Pathol Lab Med. 2020 Mar 17. doi: 10.5858/arpa.2020-0901-SA. [Epub ahead of print]
Abstract
The emergence of a novel coronavirus, termed SARS-CoV-2, and the
potentially life-threating respiratory disease that it can produce,
COVID-19, has rapidly spread across the globe creating a massive public
health problem. Previous epidemics of many emerging
viral infections have typically resulted in poor obstetrical outcomes
including maternal morbidity and mortality, maternal-fetal transmission
of the virus, and perinatal infections and death. This communication
reviews the effects of two previous coronavirus
infections - severe acute respiratory syndrome (SARS) caused by
SARS-CoV and Middle East respiratory syndrome (MERS) caused by MERS-CoV -
on pregnancy outcomes. In addition, it analyzes literature describing
38 pregnant women with COVID-19 and their newborns
in China to assess the effects of SARS-CoV-2 on the mothers and infants
including clinical, laboratory and virologic data, and the
transmissibility of the virus from mother to fetus. This analysis
reveals that unlike coronavirus infections of pregnant women
caused by SARS and MERS, in these 38 pregnant women COVID-19 did not
lead to maternal deaths. Importantly, and similar to pregnancies with
SARS and MERS, there were no confirmed cases of intrauterine
transmission of SARS-CoV-2 from mothers with COVID-19 to
their fetuses. All neonatal specimens tested, including in some cases
placentas, were negative by rt-PCR for SARS-CoV-2. At this point in the
global pandemic of COVID-19 infection there is no evidence that
SARS-CoV-2 undergoes intrauterine or transplacental
transmission from infected pregnant women to their fetuses. Analysis of
additional cases is necessary to determine if this remains true.
|
Posibles resultados maternos e infantiles de coronavirus
(Wuhan) 2019-nCoV que infectan a mujeres embarazadas: lecciones de SARS,
MERS y otras infecciones por coronavirus humanos.
Potential Maternal and Infant
Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women:
Lessons from SARS, MERS, and Other Human Coronavirus Infections.
Schwartz DA1, Graham AL2.
Viruses. 2020 Feb 10;12(2). pii: E194. doi: 10.3390/v12020194.
Abstract
In early December 2019 a cluster of cases of pneumonia of unknown
cause was identified in Wuhan, a city of 11 million persons in the
People's Republic of China. Further investigation revealed these cases
to result from infection with a newly identified
coronavirus, termed the 2019-nCoV. The infection moved rapidly through
China, spread to Thailand and Japan, extended into adjacent countries
through infected persons travelling by air, eventually reaching multiple
countries and continents. Similar to such
other coronaviruses as those causing the Middle East respiratory
syndrome (MERS) and severe acute respiratory syndrome (SARS), the new
coronavirus was reported to spread via natural aerosols from
human-to-human. In the early stages of this epidemic the case
fatality rate is estimated to be approximately 2%, with the majority of
deaths occurring in special populations. Unfortunately, there is
limited experience with coronavirus infections during pregnancy, and it
now appears certain that pregnant women have become
infected during the present 2019-nCoV epidemic. In order to assess the
potential of the Wuhan 2019-nCoV to cause maternal, fetal and neonatal
morbidity and other poor obstetrical outcomes, this communication
reviews the published data addressing the epidemiological
and clinical effects of SARS, MERS, and other coronavirus infections on
pregnant women and their infants. Recommendations are also made for the
consideration of pregnant women in the design, clinical trials, and
implementation of future 2019-nCoV vaccines.
KEYWORDS: 2019-nCoV; China; MERS-CoV; Middle East respiratory
syndrome; SARS-CoV; Wuhan coronavirus; Wuhan coronavirus outbreak;
coronavirus; emerging infection; epidemic; maternal death; maternal
morbidity; maternal mortality; pneumonia; pregnancy;
pregnancy complications; severe acute respiratory syndrome
|
|
Posible transmisión vertical de SARS-CoV-2 de una madre infectada a su recién nacido
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn
JAMA. Published online March 26, 2020. doi:10.1001/jama.2020.4621
|
Infección neonatal de inicio temprano con SARS-CoV-2 en 33 recién nacidos de madres con COVID-19 en Wuhan, China
Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China
JAMA Pediatr. Published online March 26, 2020. doi:10.1001/jamapediatrics.
|
Nueva enfermedad del virus corona (COVID-19) en el embarazo: ¿Qué recomendaciones clínicas seguir?
Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?
Acta Obstet Gynecol Scand. 2020 Apr;99(4):439-442. doi: 10.1111/aogs.13836. Epub 2020 Mar 5.
|
Enfermedad por coronavirus 2019 (COVID-19) y embarazo: lo que los obstetras deben saber.
Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know.
Am J Obstet Gynecol. 2020 Feb 24. pii: S0002-9378(20)30197-6. doi: 10.1016/j.ajog.2020.02.017.
[Epub ahead of print]
Abstract
Coronavirus Disease 2019 (COVID-19) is an emerging disease with a
rapid increase in cases and deaths since its first identification
in Wuhan, China, in December 2019. Limited data are available
about COVID-19 during